Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)

Trial Identifier: V114-036
Sponsor: MSD
Start Date: February 2021
Primary Completion Date: November 2022
Study Completion Date: November 2022
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary – English

Trial Locations

Country Location
Korea, Republic of, Incheon Incheon, Korea, Republic of, 22332
Korea, Republic of, Incheon Incheon, Korea, Republic of, 21565
Korea, Republic of, Incheon Incheon, Korea, Republic of, 21431
Korea, Republic of, Jeonrabugdo Jeonju-si, Jeonrabugdo, Korea, Republic of, 54907
Korea, Republic of, Kyonggi-do Ansan-si, Kyonggi-do, Korea, Republic of, 15355
Korea, Republic of, Kyonggi-do Anyang-si, Kyonggi-do, Korea, Republic of, 14068
Korea, Republic of, Kyonggi-do Hwaseong-si, Kyonggi-do, Korea, Republic of, 18450
Korea, Republic of, Kyonggi-do Seongnam si, Kyonggi-do, Korea, Republic of, 13496
Korea, Republic of, Kyongsangnam-do Changwon, Kyongsangnam-do, Korea, Republic of, 51394
Korea, Republic of, Kyongsangnam-do Yangsan-si, Kyongsangnam-do, Korea, Republic of, 50612
Korea, Republic of, Seoul Seoul, Korea, Republic of, 01830
Korea, Republic of, Seoul Seoul, Korea, Republic of, 06351
Korea, Republic of, Seoul Seoul, Korea, Republic of, 03722
Korea, Republic of, Seoul Seoul, Korea, Republic of, 06591
Korea, Republic of, Seoul Seoul, Korea, Republic of, 01812
Korea, Republic of, Seoul Seoul, Korea, Republic of, 06973
Korea, Republic of, Seoul Seoul, Korea, Republic of, 07804
Korea, Republic of, Seoul Seoul, Korea, Republic of, 08308
Korea, Republic of, Taegu-Kwangyokshi Daegu, Taegu-Kwangyokshi, Korea, Republic of, 41944